(Medical Xpress) -- Scientists in a team at Newcastle University have identified a mechanism by which treatment-related leukaemia develops, raising hopes that this side effect of toxic chemotherapy could be prevented.
May 31, 2012
0
0
Using fractionated doses of the targeted anticancer drug gemtuzumab ozogamicin allows for safer delivery of the drug into patients aged 50-70 years with acute myeloid leukaemia (AML) and substantially improves their outcomes. ...
Apr 4, 2012
0
0
(Medical Xpress) -- Cancer Research UK scientists have discovered a promising new approach to treat a type of myeloid leukaemia – a cancer with limited treatment options and relatively poor survival, according to research ...
Mar 30, 2012
0
0
Cancer Research UK’s Drug Development Office has opened the first trial of a new type of drug to treat children aged from six months to 18 years with acute leukaemia, who are no longer responding to treatment.
Jan 27, 2012
0
0
Selecting better matched recipients and donors than is currently required for umbilical-cord blood transplantation could substantially reduce transplant-related deaths. The findings, published Online First in the Lancet Oncology ...
Oct 6, 2011
0
0
A genomic study of chronic blood cancer - a precursor to leukaemia - has discovered gene mutations that could enable diagnosis using only a blood test, avoiding the need for an invasive and painful bone marrow biopsy.
Sep 26, 2011
0
0
(Medical Xpress) -- Researchers at the UCL Institute of Child Health have developed gene-therapy programmes that can successfully treat children born with an inability to fight infections, according to studies published today ...
Aug 25, 2011
0
0
(Medical Xpress) -- A trial of a new drug for patients with hereditary breast or ovarian cancer at an advanced stage has been launched at the University of Oxford.
Aug 17, 2011
0
0
(Medical Xpress) -- Taller people are at increased risk of a wide range of cancers, according to new research led by Oxford University.
Jul 22, 2011
1
0
Researchers from the University of Sheffield have discovered valuable insight into how people develop B-cell lymphoma, one of the most common cancers in the UK.
Jun 9, 2011
0
0
